Journals / Journal of Experimental and Clinical Medicine / 2021 / Volume: 38 Issue: 4

The Dilemma of Cesarean Myomectomy: Is It Safe or Not

Pages
—
Publication Date
2021-10-09
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It also offers the advantage of avoiding a second operation in patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives To evaluate the safety and effectiveness of myomectomy during cesarean section Methods The data of fifty-four pregnants who underwent cesarean myomectomy and twenty-six pregnant with uterine leiomyoma who had cesarean section without myomectomy between the years of 2017 and 2020 in our tertiary clinic were examined retrospectively.
📊
Key Findings & Data:Results There was no significant difference in terms of maternal age, weeks of gestation, gravida, parity, use of additional uterotonics, type of leiomyoma, size of leiomyoma, cesarean indications, blood transfusion requirement, postoperative fever, preoperative hemoglobin (g/dl), change in hemoglobin (g/dl), preoperative hematocrit (%), change in hematocrit (%), length of hospital stay between the two groups (p ˃ 0.05).
💡
Conclusion & Impact:It also offers the advantage of avoiding a second operation in patients.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Cesarean · Leiomyoma · Pregnancy

Abstract

Objectives To evaluate the safety and effectiveness of myomectomy during cesarean section Methods The data of fifty-four pregnants who underwent cesarean myomectomy and twenty-six pregnant with uterine leiomyoma who had cesarean section without myomectomy between the years of 2017 and 2020 in our tertiary clinic were examined retrospectively. Results There was no significant difference in terms of maternal age, weeks of gestation, gravida, parity, use of additional uterotonics, type of leiomyoma, size of leiomyoma, cesarean indications, blood transfusion requirement, postoperative fever, preoperative hemoglobin (g/dl), change in hemoglobin (g/dl), preoperative hematocrit (%), change in hematocrit (%), length of hospital stay between the two groups (p ˃ 0.05). While no significant difference was observed according to the location of the leiomyomas between the anterior, fundal and posterior location between the two groups, cervical leiomyomas were significantly higher in the CS group (p ˂ 0.05). Conclusion This study shows that cesarean myomectomy is a safe procedure in selected cases. It also offers the advantage of avoiding a second operation in patients.

🔖

Cite This Article

Gürsoy, A., Atasayan, K., Tekbaş, E. D., İlter, E. (2021). The Dilemma of Cesarean Myomectomy: Is It Safe or Not. Journal of Experimental and Clinical Medicine, Volume: 38 Issue: 4. https://ajindex.com/articles/1423163

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (29)

  1. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435-438. doi:10.1093/ajcp/94.4.435
  2. Lam SJ, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome. Am J Obstet Gynecol. 2014;211(4):395.e1-395.e3955. doi:10.1016/j.ajog.2014.03.066
  3. Milazzo GN, Catalano A, Badia V, Mallozzi M, Caserta D. Myoma and myomectomy: Poor evidence concern in pregnancy. J Obstet Gynaecol Res. 2017;43(12):1789-1804. doi:10.1111/jog.13437
  4. Deveer M, Deveer R, Engin-Ustun Y, et al. Comparison of pregnancy outcomes in different localizations of uterine fibroids. Clin Exp Obstet Gynecol. 2012;39(4):516-518.
  5. Chauhan AR. Cesarean myomectomy: necessity or opportunity? J Obstet Gynecol India. 2018;68(6):432–6. https://doi.org/10.1007/ s13224-018-1114-8.
  6. Sarwar I, Habib S, Bibi A, Malik N, Parveen Z. Clinical audit of foetomaternal outcome in pregnancies with fibroid uterus. J Ayub Med Coll Abbottabad. 2012;24(1):79-82.
  7. Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006;108(3 Pt 1):573-581. doi:10.1097/01.AOG.0000233155.62906.6d
  8. Obara M, Hatakeyama Y, Shimizu Y. Vaginal Myomectomy for Semipedunculated Cervical Myoma during Pregnancy. AJP Rep. 2014;4(1):37-40. doi:10.1055/s-0034-1370352
  9. Sparić R, Kadija S, Stefanović A, et al. Cesarean myomectomy in modern obstetrics: More light and fewer shadows. J Obstet Gynaecol Res. 2017;43(5):798-804. doi:10.1111/jog.13294
  10. Sparić R. Srp Arh Celok Lek. 2014;142(1-2):118-124. doi:10.2298/sarh1402118s
  11. Sparić R, Malvasi A, Tinelli A. Analysis of clinical, biological and obstetric factors influencing the decision to perform cesarean myomectomy. Ginekol Pol. 2015;86(1):40-45. doi:10.17772/gp/1897
  12. Sparić R, Malvasi A, Kadija S, Babović I, Nejković L, Tinelli A. Cesarean myomectomy trends and controversies: an appraisal. J Matern Fetal Neonatal Med. 2017;30(9):1114-1123. doi:10.1080/14767058.2016.1205024
  13. Tinelli A, Mynbaev OA, Sparic R, et al. Angiogenesis and Vascularization of Uterine Leiomyoma: Clinical Value of Pseudocapsule Containing Peptides and Neurotransmitters. Curr Protein Pept Sci. 2017;18(2):129-139. doi:10.2174/1389203717666160322150338
  14. Song D, Zhang W, Chames MC, Guo J. Myomectomy during cesarean delivery. Int J Gynaecol Obstet. 2013;121(3):208-213. doi:10.1016/j.ijgo.2013.01.021
  15. Incebiyik A, Hilali NG, Camuzcuoglu A, Vural M, Camuzcuoglu H. Myomectomy during caesarean: a retrospective evaluation of 16 cases. Arch Gynecol Obstet. 2014;289(3):569-573. doi:10.1007/s00404-013-3019-1
  16. Dedes I, Schäffer L, Zimmermann R, Burkhardt T, Haslinger C. Outcome and risk factors of cesarean delivery with and without cesarean myomectomy in women with uterine myomatas. Arch Gynecol Obstet. 2017;295(1):27-32. doi:10.1007/s00404-016-4177-8
  17. Özcan A, Kopuz A, Turan V, et al. Cesarean myomectomy for solitary uterine fibroids: Is it a safe procedure?. Ginekol Pol. 2016;87(1):54-58. doi:10.17772/gp/57833
  18. Kwon DH, Song JE, Yoon KR, Lee KY. The safety of cesarean myomectomy in women with large myomas. Obstet Gynecol Sci. 2014;57(5):367-372. doi:10.5468/ogs.2014.57.5.367
  19. Topçu HO, İskender CT, Timur H, Kaymak O, Memur T, Danışman N. Outcomes after cesarean myomectomy versus cesarean alone among pregnant women with uterine leiomyomas. Int J Gynaecol Obstet. 2015;130(3):244-246. doi:10.1016/j.ijgo.2015.03.035
  20. Simsek Y, Celen S, Danisman N, Mollamahmutoğlu L. Removal of uterine fibroids during cesarean section: a difficult therapeutic decision. Clin Exp Obstet Gynecol. 2012;39(1):76-78.
  21. Doğan S, Özyüncü Ö, Atak Z. Fibroids During Pregnancy: Effects on Pregnancy and Neonatal Outcomes. J Reprod Med. 2016;61(1-2):52-57.
  22. Zaima A, Ash A. Fibroid in pregnancy: characteristics, complications, and management. Postgrad Med J. 2011;87(1034):819-828. doi:10.1136/postgradmedj-2011-130319
  23. Roman AS, Tabsh KM. Myomectomy at time of cesarean delivery: a retrospective cohort study. BMC Pregnancy Childbirth. 2004;4(1):14. Published 2004 Jul 16. doi:10.1186/1471-2393-4-14
  24. Pergialiotis V, Sinanidis I, Louloudis IE, Vichos T, Perrea DN, Doumouchtsis SK. Perioperative Complications of Cesarean Delivery Myomectomy: A Meta-analysis. Obstet Gynecol. 2017;130(6):1295-1303. doi:10.1097/AOG.0000000000002342
  25. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211.e1-211.e2119. doi:10.1016/j.ajog.2011.12.002
  26. Hassiakos D, Christopoulos P, Vitoratos N, Xarchoulakou E, Vaggos G, Papadias K. Myomectomy during cesarean section: a safe procedure?. Ann N Y Acad Sci. 2006;1092:408-413. doi:10.1196/annals.1365.038
  27. Kaymak O, Ustunyurt E, Okyay RE, Kalyoncu S, Mollamahmutoglu L. Myomectomy during cesarean section. Int J Gynaecol Obstet. 2005;89(2):90-93. doi:10.1016/j.ijgo.2004.12.035
  28. Park BJ, Kim YW. Safety of cesarean myomectomy. J Obstet Gynaecol Res. 2009;35(5):906-911. doi:10.1111/j.1447-0756.2009.01121.x
  29. Knight J, Falcone T. Tissue extraction by morcellation: a clinical dilemma. J Minim Invasive Gynecol. 2014;21(3):319-320. doi:10.1016/j.jmig.2014.03.005